Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Pivanex Plus Docetaxel or Docetaxel Monotherapy in Patients With Chemotherapy Resistant Advanced Non-Small Cell Carcinoma of the Lung (NSCLC)

NCT00073385 is registered in ClinicalTrials.gov with Titan Pharmaceuticals as lead sponsor.

NCT NCT00073385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00073385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Pivanex Plus Docetaxel or Docetaxel Monotherapy in Patients With Chemotherapy Resistant Advanced Non-Small Cell Carcinoma of the Lung (NSCLC)
Lead sponsor
Titan Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2003
Completion date
October 31, 2004
Enrollment
225
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung